US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Xtrackers Nifty 500 India ETF

22.22

0.0000

Volume:61

Turnover:1.35K

Market Cap:4.44M

PE:- -

High:22.22

Open:22.22

Low:22.22

Close:22.22

52wk High:27.40

52wk Low:20.52

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.04

T/O Rate:0.03%

Dividend:0.08

Dividend Rate:0.35%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Industrial Minerals Completes Galleon Deal and Reshapes Board

Nxera to Book US$10m Milestone as FDA Clears Phase 2 Alzheimer’s Drug

Is HBM Holdings (SEHK:2142) Fully Valued After Its HBM7004 IND Approval?

Simply Wall St.

Caliway Gets FDA IND Nod for Phase 2 CBL-514 Trial of Abdominal Fat Reduction Drug; Shares Down 4%

MT Newswires Live

Press Release: InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved

Industrial Minerals Confirms Priority Gold Target at Laverton’s North Pool

Industrial Minerals Wins Strong Shareholder Backing for Galleon Metals Deal and Board Refresh

CSTONE PHARMA-B Gets NMPA Green Light for CS5007 Investigational New Drug Application

CStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS5007

Protagenic Therapeutics Advances PT00114 Toward U.S. IND

Protagenic receives FDA pre-IND feedback supporting IND for PT00114

India's Central Bank Chief Says Its Net Short Dollar Position Is 'Very Manageable'

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

Asia's Least Favored Stock Market Has Shifted, According to BofA Fund Manager Poll

Abbisko Wins China IND Nod for Pan-KRAS Cancer Drug ABSK211

Traders Report RBI Continues Selling Dollars to Bolster Rupee Exchange Rate

CARsgen Therapeutics Holdings (SEHK:2171) Gains On CT0596 IND Clearance, But Is The Valuation Too Rich

Simply Wall St.

Trump: University of Miami donates 1994 Ibogaine IND to accelerate treatment for veterans

Trump's Truth Social latest posts

Citi Expresses Optimism on Indian Equities, Adds Axis Bank to Top Picks List

Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/IND/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","market":"US","secType":"STK","nameCN":"Xtrackers Nifty 500 India ETF","latestPrice":22.22,"timestamp":1789752933360,"preClose":22.22,"halted":0,"volume":61,"delay":0,"changeRate":0,"floatShares":200001,"shares":200001,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-18 14:09:32 EDT","open":22.22,"high":22.22,"low":22.22,"amount":1353.4782480000001,"amplitude":0,"askPrice":22.35,"askSize":100,"bidPrice":22.19,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":22.22,"sharesOutstanding":200001,"nav":21.995,"aum":4399044.94,"dividendRate":0.00347,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":22.32,"preClose":22.22,"latestTime":"16:10 EDT","volume":6,"amount":133.32,"timestamp":1789675804181,"change":0.1,"changeRate":0.0045,"amplitude":0},"volumeRatio":0.043182},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","floatShares":200001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.043182,"shares":200001,"dividePrice":0.0771,"high":22.22,"amplitude":0,"preClose":22.22,"low":22.22,"week52Low":20.515,"pbRate":"--","week52High":27.4,"institutionHeld":0,"latestPrice":22.22,"eps":0,"divideRate":0.00347,"volume":61,"delay":0,"ttmEps":0,"open":22.22,"prevYearClose":24.78,"prevWeekClose":22.5807,"prevMonthClose":23.145,"prevQuarterClose":22.88,"fiveDayClose":22.5807,"twentyDayClose":22.885,"sixtyDayClose":23.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IND\",params:#limit:5,,,undefined,":[{"date":"2026-06-18","symbol":"IND","amount":0.07775,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Xtrackers Nifty 500 India ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IND\",market:\"US\",,,undefined,":[{"executeDate":"2026-06-18","recordDate":"2026-06-18","paymentDate":"2026-06-26","value":0.07775,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IND\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IND\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662780987","title":"Industrial Minerals Completes Galleon Deal and Reshapes Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2662780987","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662780987?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:49","pubTimestamp":1787809799,"startTime":"0","endTime":"0","summary":"Industrial Minerals Limited ( ($AU:IND) ) has provided an announcement. Industrial Minerals Ltd, an Australian exploration company, is building a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-completes-galleon-deal-and-reshapes-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-completes-galleon-deal-and-reshapes-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","MTX","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795913","title":"Nxera to Book US$10m Milestone as FDA Clears Phase 2 Alzheimer’s Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795913","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662795913?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:52","pubTimestamp":1787730745,"startTime":"0","endTime":"0","summary":"Sosei Group ( ($JP:4565) ) has provided an update. Nxera Pharma’s partner Neurocrine Biosciences has secured FDA IND acceptance for a Phase 2 trial...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nxera-to-book-us10m-milestone-as-fda-clears-phase-2-alzheimers-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nxera-to-book-us10m-milestone-as-fda-clears-phase-2-alzheimers-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","PSIL","BBC","IND","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662349759","title":"Is HBM Holdings (SEHK:2142) Fully Valued After Its HBM7004 IND Approval?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662349759","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662349759?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:18","pubTimestamp":1787674691,"startTime":"0","endTime":"0","summary":"HBM Holdings (SEHK:2142) is back in focus after Harbour BioMed received approval from China’s National Medical Products Administration for an Investigational New Drug application linked to HBM7004, a bispecific antibody targeting advanced solid tumors.\nSee our latest analysis for HBM Holdings.\nThe HBM7004 IND approval arrives as HBM Holdings trades at HK$16.54, with a 30-day share price return of 32.21% and a 90-day share price return of 40.77%, while the 3-year total shareholder return is...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/is-hbm-holdings-sehk2142-fully-valued-after-its-hbm7004-ind","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/is-hbm-holdings-sehk2142-fully-valued-after-its-hbm7004-ind","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DRMY","RAM","MUU","MIC","MUZ","BK4588","MUD","BK1161","MULL","HBMX","DISK","HBM","MUG","IND","02142","DCF","COPP","DRAM","DRMP","BK1574","RAMZ","BK1583","MUYY","DRAL","BK4168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778308","title":"Caliway Gets FDA IND Nod for Phase 2 CBL-514 Trial of Abdominal Fat Reduction Drug; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778308","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778308?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:19","pubTimestamp":1787631588,"startTime":"0","endTime":"0","summary":"Caliway Biopharmaceuticals Co Ltd  has received approval from the U.S. Food and Drug Administration for an investigational new drug application for a second-phase trial of the combination use of CBL-514 and Zepbound to reduce abdominal subcutaneous fat in overweight or obese adults.The company plans to enroll 120 subjects in the US for Phase 2 of the trial to evaluate the efficacy, safety, and tolerability of the combination use of CBL-514 and tirzepatide, according to a Monday filing to the Taiwan stock exchange.The company's shares were down nearly 4% in Tuesday's trade.This study will evaluate abdominal fat volume change measured by MRI as an efficacy endpoint.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBL","BK4588","BK4585","BK4231","IND","LABU","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661695272","title":"Press Release: InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved","url":"https://stock-news.laohu8.com/highlight/detail?id=2661695272","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661695272?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:32","pubTimestamp":1787581920,"startTime":"0","endTime":"0","summary":"BEIJING, Aug. 24, 2026  -- InnoCare Pharma , a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the interim results and business highlights for the six months ended 30 June 2026.InnoCare delivered robust revenue growth and strengthened profitability in the first half of 2026, driven by strong commercial execution and global business development collaborations. In the first half of 2026, the Company's revenue grew by 55.5% year-on-year to RMB 1.1 billion, and profit reached RMB 239.7 million, a turnaround from a loss in the same period last year. These results reflect the successful implementation of the Company's strategy driven by innovation, commercialization and globalization.In the first half of 2026, InnoCare continued to accelerate innovation, achieving a series of key milestones.-- 1 NDA approval: Orelabrutinib was approved in Australia.-- 2 NDA acceptances: The NDA applications for orelabrutinib in primary. immune thrombocytopenia  a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4161","BK4195","CR","BK4567","BK4121","IE00BYQQ9H92.USD","BK4211","ORR","LU1093756325.SGD","BK1574","BK4077","LU2413666699.HKD","LU2413666426.HKD","SLE","09969","LU2211817866.USD","BK4533","LU0347712357.USD","IND","LU1093756168.USD","BK1161","MTD","LU1721428933.USD","PFS","BK4199","BK4588","IE00B5TLWC47.USD","BK4548","IE00BFXG0V08.USD","ITP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661048246","title":"Industrial Minerals Confirms Priority Gold Target at Laverton’s North Pool","url":"https://stock-news.laohu8.com/highlight/detail?id=2661048246","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661048246?lang=en_us&edition=fundamental","pubTime":"2026-08-24 06:39","pubTimestamp":1787524775,"startTime":"0","endTime":"0","summary":"Industrial Minerals Limited ( ($AU:IND) ) has issued an update. Industrial Minerals has reinterpreted existing aeromagnetic and gravity data over t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-confirms-priority-gold-target-at-lavertons-north-pool?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-confirms-priority-gold-target-at-lavertons-north-pool?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4559","BK4588","BK4159","MTX","BK4109","POOL","IND","BK4567","IE00B64QTZ34.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661251858","title":"Industrial Minerals Wins Strong Shareholder Backing for Galleon Metals Deal and Board Refresh","url":"https://stock-news.laohu8.com/highlight/detail?id=2661251858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661251858?lang=en_us&edition=fundamental","pubTime":"2026-08-21 11:17","pubTimestamp":1787282249,"startTime":"0","endTime":"0","summary":"Industrial Minerals Limited ( ($AU:IND) ) has shared an announcement. Industrial Minerals Limited shareholders have overwhelmingly approved all res...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-wins-strong-shareholder-backing-for-galleon-metals-deal-and-board-refresh?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-wins-strong-shareholder-backing-for-galleon-metals-deal-and-board-refresh?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PICK","MTX","BK4535","IND","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163462206","title":"CSTONE PHARMA-B Gets NMPA Green Light for CS5007 Investigational New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1163462206","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163462206?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:12","pubTimestamp":1787263936,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) has announced that the Investigational New Drug (IND) application for CS5007, an EGFR/HER3 bispecific antibody-drug conjugate (ADC) and one of the core candidates in the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","ADC","NETL","BK4080","IND","02616","BK4231","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661302932","title":"CStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS5007","url":"https://stock-news.laohu8.com/highlight/detail?id=2661302932","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661302932?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:07","pubTimestamp":1787263635,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals ( ($HK:2616) ) just unveiled an announcement. CStone Pharmaceuticals has secured rapid investigational new drug approval in ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cstone-gains-rapid-china-ind-approval-for-egfr-her3-adc-cs5007?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cstone-gains-rapid-china-ind-approval-for-egfr-her3-adc-cs5007?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4080","IND","NETL","TBXU","PSIL","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661235479","title":"Protagenic Therapeutics Advances PT00114 Toward U.S. IND","url":"https://stock-news.laohu8.com/highlight/detail?id=2661235479","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661235479?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:04","pubTimestamp":1787241844,"startTime":"0","endTime":"0","summary":"Protagenic Therapeutics ( ($PTIX) ) has issued an announcement. On August 20, 2026, Protagenic Therapeutics announced that the U.S. Food and Drug A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/protagenic-therapeutics-advances-pt00114-toward-u-s-ind?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/protagenic-therapeutics-advances-pt00114-toward-u-s-ind?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","IND","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660735282","title":"Protagenic receives FDA pre-IND feedback supporting IND for PT00114","url":"https://stock-news.laohu8.com/highlight/detail?id=2660735282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660735282?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:50","pubTimestamp":1787230244,"startTime":"0","endTime":"0","summary":"Protagenic Therapeutics (PTIX) announced that it has received written responses from the U.S. Food and Drug Administration, FDA, to its Type B pre-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagenic-receives-fda-pre-ind-feedback-supporting-ind-for-pt00114-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagenic-receives-fda-pre-ind-feedback-supporting-ind-for-pt00114-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LABU","IND","BK4588","PTIX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122741128","title":"India's Central Bank Chief Says Its Net Short Dollar Position Is 'Very Manageable'","url":"https://stock-news.laohu8.com/highlight/detail?id=1122741128","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122741128?lang=en_us&edition=fundamental","pubTime":"2026-08-20 10:40","pubTimestamp":1787193618,"startTime":"0","endTime":"0","summary":"Reserve Bank of India Governor Sanjay Malhotra stated that the central bank's net forward short dollar position remains at a \"very manageable\" level, citing prior liquidity swap arrangements and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIND","TAJX","FLIBF","IMVP","IOPP","INDL","BK4588","NDIA","BK4585","INQQ","IND","UUP","NFTY","INCO","UDN","INDA","FLIN","SMIN","BK4523","EPI","INDE","PIN","SCIN","INDY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660474641","title":"Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2660474641","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660474641?lang=en_us&edition=fundamental","pubTime":"2026-08-20 08:32","pubTimestamp":1787185920,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Aug.  20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, \"Telix\") today announces its financial results for the period ended June","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/20/3348062/0/en/telix-2026-half-year-results-strong-commercial-execution-and-momentum-in-late-stage-pipeline.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX","BK4530","BK4017","BK4141","BK4215","LU1223082196.USD","BK4139","BK4526","IE00BFMHRM44.USD","SPRE","IND","TMS","LU1223082519.USD","SGDM","SIL","ASX","MAA","BK4588","BK4543","XME","GDXJ","LU1223083913.SGD","BK4585","LU0390134368.USD","CDE","LU0757428866.USD","LU0029874061.USD","BK4121","CRL","LU0128526141.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129083876","title":"Asia's Least Favored Stock Market Has Shifted, According to BofA Fund Manager Poll","url":"https://stock-news.laohu8.com/highlight/detail?id=1129083876","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129083876?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:07","pubTimestamp":1787130439,"startTime":"0","endTime":"0","summary":"A recent survey conducted by Bank of America among fund managers reveals a notable shift in regional sentiment, with India now overtaking Indonesia as the most underweighted equity market in Asia....","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDY","PIN","EQLT","EET","XC","INDL","MEM","BK4588","AVEM","BKF","EEMV","EMES","QEMM","RAYE","MEMX","INCO","STXE","BK4585","BK4523","HEEM","SCHE","SCIN","BBEM","QLVE","TEMR","XCNY","DEXC","SEEM","TEMX","VEU","IMVP","NDIA","EPI","ASIA","VEXC","NFTY","BKEM","GIND","FLIN","GLIN","MFEM","XXCH","EMXC","PEMX","INDE","XSOE","RWEM","BK4550","DFAE","FEMR","XCEM","BCHI","FLIBF","IND","INQQ","INDA","EEMA","INDH","SPEM","AEF","SMIN","KEMX","INDQ","TAJX","INDZ","IOPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660858414","title":"Abbisko Wins China IND Nod for Pan-KRAS Cancer Drug ABSK211","url":"https://stock-news.laohu8.com/highlight/detail?id=2660858414","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660858414?lang=en_us&edition=fundamental","pubTime":"2026-08-19 12:38","pubTimestamp":1787114321,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited ( ($HK:2256) ) has provided an update. Abbisko Therapeutics has secured Investigational New Drug clearance from China’s Nati...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-china-ind-nod-for-pan-kras-cancer-drug-absk211?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-china-ind-nod-for-pan-kras-cancer-drug-absk211?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189195744","title":"Traders Report RBI Continues Selling Dollars to Bolster Rupee Exchange Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=1189195744","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189195744?lang=en_us&edition=fundamental","pubTime":"2026-08-19 12:04","pubTimestamp":1787112277,"startTime":"0","endTime":"0","summary":"According to informed traders, the Indian central bank is actively selling US dollars in the domestic foreign exchange market to support the rupee's exchange rate. These traders requested anonymity...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDN","IND","INCO","NFTY","SCIN","IMVP","SMIN","GIND","UUP","TAJX","BK4585","INDL","FLIBF","PIN","IOPP","FLIN","BK4523","INDA","INQQ","EPI","BK4588","NDIA","INDY","INDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660494978","title":"CARsgen Therapeutics Holdings (SEHK:2171) Gains On CT0596 IND Clearance, But Is The Valuation Too Rich","url":"https://stock-news.laohu8.com/highlight/detail?id=2660494978","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660494978?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:24","pubTimestamp":1787077458,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings (SEHK:2171) has drawn fresh attention after its allogeneic CAR T-cell candidate CT0596 received IND clearance from China’s National Medical Products Administration for relapsed or refractory multiple myeloma.\nSee our latest analysis for CARsgen Therapeutics Holdings.\nThe CT0596 IND clearance arrives as CARsgen Therapeutics Holdings trades at HK$14.7, with a 1 day share price return of 2.15% and a 90 day share price return down 16.62%. The 1 year total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk2171-gains-on-ct0596-ind-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk2171-gains-on-ct0596-ind-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","BK1585","BK1587","BK4007","BK4139","IND","BK4539","BK1161","BK1574","02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660949985","title":"Trump: University of Miami donates 1994 Ibogaine IND to accelerate treatment for veterans","url":"https://stock-news.laohu8.com/highlight/detail?id=2660949985","media":"Trump's Truth Social latest posts","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660949985?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:57","pubTimestamp":1787072260,"startTime":"0","endTime":"0","summary":"President Donald Trump announced on August 18 that the University of Miami has donated its original 1994 Ibogaine Investigational New Drug (IND) application to the federal government, a move he said...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://trumpstruth.org/statuses/40964","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND.AU","IND","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180340970","title":"Citi Expresses Optimism on Indian Equities, Adds Axis Bank to Top Picks List","url":"https://stock-news.laohu8.com/highlight/detail?id=1180340970","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180340970?lang=en_us&edition=fundamental","pubTime":"2026-08-17 13:20","pubTimestamp":1786944032,"startTime":"0","endTime":"0","summary":"Citi has expressed a positive outlook on the Indian stock market, driven by better-than-expected first-quarter earnings and the Nifty 50 index trading near its long-term average valuation. Analysts...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDY","LU1244550577.SGD","LU0128525689.USD","LU1668664300.SGD","LU2236285917.USD","GLIN","LU0130102774.USD","LU0052756011.USD","LU1162221912.USD","161121","LU0314106906.USD","BK4585","BK4566","FLIN","IE00BSNM7G36.USD","BK4559","INCO","LU1074936037.SGD","LU1201861249.SGD","BK4207","FLIBF","EPI","LU1244550221.USD","LU2360032135.SGD","FTXO","MNDmain","LU0320765646.SGD","IND","SCIN","BK4504","LU0098860793.USD","INDA","LU0203347892.USD","LU0648001328.SGD","C","LU0130517989.USD","LU0980610538.SGD","LU2125154778.USD","INQQ","LU2456880835.USD","LU2462157665.USD","BK4534","INDE","LU0072461881.USD","LU2417539215.USD","LU0106831901.USD","LU1267930227.SGD","LU1366192091.USD","NDIA","TFNS","LU0203345920.USD","LU1791807156.HKD","IYF","LU1506573853.SGD","BK4588","LU0162691827.USD","LU2125154935.USD","LU1244550494.USD","BK4523","INDL","NFTY","SMIN","LU0170899867.USD","LU0477156953.USD","PIN","LU0310800965.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126775","title":"Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126775","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126775?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:05","pubTimestamp":1786737900,"startTime":"0","endTime":"0","summary":"EB-003 Development Highlights:--  Continued advancing IND-enabling studies supporting the planned. submission of an Investigational New Drug  application for EB-003. --  Reported preclinical data demonstrating that EB-003 consistently. exhibited a non-hallucinogenic profile in a highly sensitive. --  Announced promising results from preclinical in vitro experiments. indicating no photoreactive potential for EB-003, further derisking its. continued development as a potential treatment of neuropsychiatric. --  Initiated genotoxicity studies to evaluate the potential for EB-003 to. interact with DNA and cause genetic mutations, a critical measure of. --  Secured U.S. Patent No. 12,605,361 pertaining to the Company's EVM301. Series of molecules being developed as potential treatments for mental","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4555","ENVB","IND","BK4588","03160","MEDX","TM","IDNA","HYLG","GDOC","BK4585","BK4007","NVIB","BK4604"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}